Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...

The stock's fall snapped a four-day winning streak.

Piper Sandler analyst Jason Bednar maintained a Buy rating on Henry Schein (HSIC – Research Report) today and set a price target of ...

Meeting to be held on March 10 at 11 am hosted by Oppenheimer. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Henry Schein Inc. (HSIC) on Tuesday reported fourth-quarter profit of $94 million. The Melville, New York-based company said it had net income of 74 cents ...

Henry Schein has acquired R. Weinstein, Inc., a provider of vaccines, medical-surgical products and equipment to Hawaii-based health care facilities and practitioners.

Henry Schein Inc. closed 14.16% short of its 52-week high of $82.49, which the company reached on February 5th.

In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is ...

Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Henry Schein HSIC in the last three months. The table below summarizes their recent ratings ...